SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-003713
Filing Date
2018-01-25
Accepted
2018-01-25 17:12:09
Documents
6
Period of Report
2018-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv484090_8k.htm 8-K 29550
2 EXHIBIT 1.1 tv484090_ex1-1.htm EX-1.1 241652
3 EXHIBIT 5.1 tv484090_ex5-1.htm EX-5.1 7156
4 EXHIBIT 99.1 tv484090_ex99-1.htm EX-99.1 10506
5 EXHIBIT 99.2 tv484090_ex99-2.htm EX-99.2 10850
6 GRAPHIC image_001.jpg GRAPHIC 7499
  Complete submission text file 0001144204-18-003713.txt   311602
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 18549049
SIC: 2836 Biological Products, (No Diagnostic Substances)